Market Reaction to China's Rare Earth Export Ban

In a dramatic turn of events, GE HealthCare witnessed a staggering 14.02% drop in its stock price, plummeting to $61.9050 per share at 9:47 am. This sharp decline comes in the wake of China's unexpected ban on rare earth exports, a move that has sent shockwaves through the global market.

What This Means for the Future

As the situation unfolds, investors and industry analysts are closely monitoring the impact of China's decision on global supply chains and the healthcare technology sector. More updates to follow...